{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:06:37Z","timestamp":1762913197278,"version":"3.45.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jvacx.2021.100105","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T09:03:22Z","timestamp":1624525402000},"page":"100105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Invaplex functions as an intranasal adjuvant for subunit and DNA vaccines co-delivered in the nasal cavity of nonhuman primates"],"prefix":"10.1016","volume":"8","author":[{"given":"Jeremy V.","family":"Camp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Singletary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Aldovini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin V.","family":"Oaks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela A.","family":"Kozlowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2021.100105_b0005","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/339710","article-title":"Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa","volume":"185","author":"Brokstad","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jvacx.2021.100105_b0010","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.4049\/jimmunol.1203254","volume":"191","author":"Clarke","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jvacx.2021.100105_b0015","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.4049\/jimmunol.168.6.2930","article-title":"Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines","volume":"168","author":"Asahi","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jvacx.2021.100105_b0020","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.4049\/jimmunol.146.6.1972","article-title":"Passive transfer of local immunity to influenza virus infection by IgA antibody","volume":"146","author":"Renegar","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.jvacx.2021.100105_b0025","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","article-title":"Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract","volume":"173","author":"Renegar","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jvacx.2021.100105_b0030","doi-asserted-by":"crossref","first-page":"7793","DOI":"10.1128\/JVI.00979-13","article-title":"Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs","volume":"87","author":"Seibert","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jvacx.2021.100105_b0035","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jvacx.2021.100105_b0040","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/mtm.2015.18","article-title":"Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates","volume":"2","author":"Pierantoni","year":"2015","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jvacx.2021.100105_b0045","doi-asserted-by":"crossref","unstructured":"Li K, Li Z, Wohlford-Lenane C, Meyerholz DK, Channappanavar R, An D, et al. Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection. mBio. 2020;11.","DOI":"10.1128\/mBio.00554-20"},{"key":"10.1016\/j.jvacx.2021.100105_b0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2019.01.002","article-title":"Single mucosal vaccination targeting nucleoprotein provides broad protection against two lineages of influenza B virus","volume":"163","author":"Kim","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jvacx.2021.100105_b0055","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fimmu.2019.00646","article-title":"Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization","volume":"10","author":"Bhide","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jvacx.2021.100105_b0060","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jinf.2019.02.003","article-title":"Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults","volume":"78","author":"Green","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.jvacx.2021.100105_b0065","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/infdis\/jiz603","article-title":"Live Respiratory Syncytial Virus Attenuated by M2\u20132 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children","volume":"221","author":"McFarland","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jvacx.2021.100105_b0070","first-page":"1","article-title":"Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults","author":"Scaggs Huang","year":"2020","journal-title":"Hum Vaccin Immunother."},{"key":"10.1016\/j.jvacx.2021.100105_b0075","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1172\/JCI135020","article-title":"Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans","volume":"130","author":"Lin","year":"2020","journal-title":"J Clin Invest."},{"key":"10.1016\/j.jvacx.2021.100105_b0080","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.169.1.566","article-title":"Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle","volume":"169","author":"Kozlowski","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jvacx.2021.100105_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112556","article-title":"Intranasal administration of a therapeutic HIV vaccine (Vacc-4x) induces dose-dependent systemic and mucosal immune responses in a randomized controlled trial","volume":"9","author":"Brekke","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jvacx.2021.100105_b0090","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1128\/IAI.67.6.2884-2890.1999","article-title":"Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit","volume":"67","author":"Rudin","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.jvacx.2021.100105_b0095","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1128\/JVI.03531-12","article-title":"Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes","volume":"87","author":"Manrique","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jvacx.2021.100105_b0100","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1172\/JCI119286","article-title":"Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses","volume":"99","author":"Quiding-Jarbrink","year":"1997","journal-title":"J Clin Invest."},{"key":"10.1016\/j.jvacx.2021.100105_b0105","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/IAI.66.2.514-520.1998","article-title":"Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates","volume":"66","author":"Johansson","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.jvacx.2021.100105_b0110","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/mi.2009.103","article-title":"Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination","volume":"2","author":"Manrique","year":"2009","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jvacx.2021.100105_b0115","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.4049\/jimmunol.1002594","article-title":"Long-term control of simian immunodeficiency virus mac251 viremia to undetectable levels in half of infected female rhesus macaques nasally vaccinated with simian immunodeficiency virus DNA\/recombinant modified vaccinia virus Ankara","volume":"186","author":"Manrique","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jvacx.2021.100105_b0120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.immuni.2011.01.015","article-title":"Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges","volume":"34","author":"Bomsel","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jvacx.2021.100105_b0125","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41591-020-0858-8","article-title":"T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers","volume":"26","author":"Arunachalam","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jvacx.2021.100105_b0130","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.1128\/JVI.00996-12","article-title":"Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following simian immunodeficiency virus challenges of vaccinated rhesus monkeys","volume":"86","author":"Stephenson","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.jvacx.2021.100105_b0135","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.vaccine.2011.02.051","article-title":"Partial efficacy of a VSV-SIV\/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques","volume":"29","author":"Marthas","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.jvacx.2021.100105_b0140","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.virol.2007.07.017","article-title":"GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA\/MVA immunodeficiency virus vaccine","volume":"369","author":"Lai","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.jvacx.2021.100105_b0145","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/JVI.00410-10","article-title":"Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian\/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques","volume":"84","author":"Xiao","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jvacx.2021.100105_b0150","doi-asserted-by":"crossref","unstructured":"Clements JD, Norton EB. The Mucosal Vaccine Adjuvant LT(R192G\/L211A) or dmLT. mSphere. 2018;3.","DOI":"10.1128\/mSphere.00215-18"},{"key":"10.1016\/j.jvacx.2021.100105_b0155","article-title":"A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection","author":"Bernasconi","year":"2020","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jvacx.2021.100105_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006999","article-title":"Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin","volume":"4","author":"Lewis","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jvacx.2021.100105_b0165","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1128\/IAI.71.2.726-732.2003","article-title":"Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a","volume":"71","author":"Mills","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.jvacx.2021.100105_b0170","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1016\/j.vaccine.2017.05.004","article-title":"Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice","volume":"35","author":"Cao","year":"2017","journal-title":"Vaccine."},{"key":"10.1016\/j.jvacx.2021.100105_b0175","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1128\/IAI.69.7.4545-4553.2001","article-title":"Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults","volume":"69","author":"Fries","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.jvacx.2021.100105_b0180","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.vaccine.2005.11.040","article-title":"Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine","volume":"24","author":"Oaks","year":"2006","journal-title":"Vaccine."},{"key":"10.1016\/j.jvacx.2021.100105_b0185","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.vaccine.2007.12.040","article-title":"Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a","volume":"26","author":"Turbyfill","year":"2008","journal-title":"Vaccine."},{"key":"10.1016\/j.jvacx.2021.100105_b0190","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2011.07.033","article-title":"Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine","volume":"29","author":"Riddle","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.jvacx.2021.100105_b0195","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1128\/IAI.74.5.2856-2866.2006","article-title":"Mucosal adjuvant properties of the Shigella invasin complex","volume":"74","author":"Kaminski","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.jvacx.2021.100105_b0200","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1128\/CVI.00435-08","article-title":"Mucosal adjuvanticity of a Shigella invasin complex with dna-based vaccines","volume":"16","author":"Kaminski","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jvacx.2021.100105_b0205","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1016\/j.vaccine.2015.07.022","article-title":"Mucosal vaccination by the intranasal route. Nose-associated lymphoid tissue (NALT)-Structure, function and species differences","volume":"33","author":"Pabst","year":"2015","journal-title":"Vaccine."},{"key":"10.1016\/j.jvacx.2021.100105_b0210","doi-asserted-by":"crossref","first-page":"10514","DOI":"10.1128\/JVI.74.22.10514-10522.2000","article-title":"Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions","volume":"74","author":"Wang","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.jvacx.2021.100105_b0215","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.4049\/jimmunol.172.6.3745","article-title":"Control of simian\/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates","volume":"172","author":"Bertley","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jvacx.2021.100105_b0220","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1128\/IAI.68.12.6624-6632.2000","article-title":"Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine","volume":"68","author":"Turbyfill","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.jvacx.2021.100105_b0225","doi-asserted-by":"crossref","first-page":"22213","DOI":"10.1073\/pnas.1015536108","article-title":"Genetic immunization in the lung induces potent local and systemic immune responses","volume":"107","author":"Song","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.jvacx.2021.100105_b0230","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00042560-200008010-00001","article-title":"Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody","volume":"24","author":"Kozlowski","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jvacx.2021.100105_b0235","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1128\/IAI.66.7.3390-3396.1998","article-title":"Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans","volume":"66","author":"Rudin","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.jvacx.2021.100105_b0240","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1128\/iai.65.4.1387-1394.1997","article-title":"Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women","volume":"65","author":"Kozlowski","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.jvacx.2021.100105_b0245","first-page":"1423","article-title":"Oral immunization studies with Streptococcus mutans and influenza vaccines in rhesus macaque monkeys","volume":"371B","author":"Michalek","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jvacx.2021.100105_b0250","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2007.04.014","article-title":"Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL","volume":"26","author":"He","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jvacx.2021.100105_b0255","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/j.gastro.2008.04.020","article-title":"Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria","volume":"135","author":"Shang","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvacx.2021.100105_b0260","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.4049\/jimmunol.0801973","article-title":"Human IgA-inducing protein from dendritic cells induces IgA production by naive IgD+ B cells","volume":"182","author":"Endsley","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jvacx.2021.100105_b0265","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1128\/IAI.66.12.5889-5896.1998","article-title":"Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination","volume":"66","author":"Eriksson","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.jvacx.2021.100105_b0270","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1023\/A:1027312223474","article-title":"Rectal immunization for induction of specific antibody in the genital tract of women","volume":"17","author":"Crowley-Nowick","year":"1997","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jvacx.2021.100105_b0275","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1128\/IAI.66.12.5630-5635.1998","article-title":"Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans","volume":"66","author":"Kantele","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.jvacx.2021.100105_b0280","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1749-6632.1994.tb44249.x","article-title":"Molecular and cellular mechanisms of tissue invasion by Shigella flexneri","volume":"730","author":"Zychlinsky","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jvacx.2021.100105_b0285","doi-asserted-by":"crossref","unstructured":"Turbyfill KR, Clarkson KA, Vortherms AR, Oaks EV, Kaminski RW. Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex. mSphere. 2018;3.","DOI":"10.1128\/mSphere.00583-17"},{"key":"10.1016\/j.jvacx.2021.100105_b0290","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/COH.0b013e3282fbaa81","article-title":"Phenotype and function of protective T cell immune responses in HIV","volume":"3","author":"Betts","year":"2008","journal-title":"Curr Opin HIV AIDS."},{"key":"10.1016\/j.jvacx.2021.100105_b0295","doi-asserted-by":"crossref","unstructured":"Aagaard C, Hoang TT, Izzo A, Billeskov R, Troudt J, Arnett K, et al. Protection and polyfunctional T cells induced by Ag85B-TB10.4\/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose. PLoS One. 2009;4:e5930.","DOI":"10.1371\/journal.pone.0005930"},{"key":"10.1016\/j.jvacx.2021.100105_b0300","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/QAI.0000000000000975","article-title":"A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk","volume":"72","author":"Butler","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jvacx.2021.100105_b0305","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1128\/IAI.67.12.6321-6328.1999","article-title":"Immunoglobulin concentrations and antigen-specific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle","volume":"67","author":"Lu","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.jvacx.2021.100105_b0310","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1365-2249.1996.36742.x","article-title":"Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation","volume":"104","author":"Kutteh","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jvacx.2021.100105_b0315","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1172\/JCI120583","article-title":"Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity","volume":"128","author":"Zalenskaya","year":"2018","journal-title":"J Clin Invest."},{"key":"10.1016\/j.jvacx.2021.100105_b0320","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.contraception.2014.02.006","article-title":"Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs","volume":"90","author":"Huijbregts","year":"2014","journal-title":"Contraception."},{"key":"10.1016\/j.jvacx.2021.100105_b0325","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/QAD.0000000000002475","article-title":"Depot medroxyprogesterone acetate administration increases cervical CCR5+CD4+ T cells and induces immunosuppressive milieu at the cervicovaginal mucosa","volume":"34","author":"Tasker","year":"2020","journal-title":"AIDS."},{"key":"10.1016\/j.jvacx.2021.100105_b0330","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/424600","article-title":"Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239","volume":"190","author":"Abel","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jvacx.2021.100105_b0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009814","article-title":"Depo-provera treatment does not abrogate protection from intravenous SIV challenge in female macaques immunized with an attenuated AIDS virus","volume":"5","author":"Genesca","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jvacx.2021.100105_b0340","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/bmj.4.5890.443","article-title":"Use of medroxyprogesterone acetate as a contraceptive in conjunction with early postpartum rubella vaccination","volume":"4","author":"Sharp","year":"1973","journal-title":"Br Med J"},{"key":"10.1016\/j.jvacx.2021.100105_b0345","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.virol.2006.04.004","article-title":"Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques","volume":"352","author":"Trunova","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.jvacx.2021.100105_b0350","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1128\/JVI.77.8.4558-4565.2003","article-title":"Progesterone increases susceptibility and decreases immune responses to genital herpes infection","volume":"77","author":"Kaushic","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jvacx.2021.100105_b0355","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1016\/j.vaccine.2006.12.001","article-title":"Induction of secretory immunity and memory at mucosal surfaces","volume":"25","author":"Brandtzaeg","year":"2007","journal-title":"Vaccine."}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259013622100022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259013622100022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:04:12Z","timestamp":1762913052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259013622100022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":71,"alternative-id":["S259013622100022X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2021.100105","relation":{},"ISSN":["2590-1362"],"issn-type":[{"type":"print","value":"2590-1362"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invaplex functions as an intranasal adjuvant for subunit and DNA vaccines co-delivered in the nasal cavity of nonhuman primates","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2021.100105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100105"}}